Susquehanna International Group’s iBio IBIO Stock Holding History

Susquehanna International Group’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-780	Closed	-$32.4K	–	12537
2023 Q1	$32.4K	Buy	+780	New	+$20.1K	﹤0.01%	11881
2022 Q4	–	Sell	-668	Closed	-$57K	–	12964
2022 Q3	$57K	Sell	668 -20	-3%	-$2.75K	﹤0.01%	12114
2022 Q2	$89K	Sell	688 -27	-4%	-$4.06K	﹤0.01%	11575
2022 Q1	$154K	Sell	715 -1,142	-61%	-$239K	﹤0.01%	11535
2021 Q4	$511K	Sell	1,857 -634	-25%	-$242K	﹤0.01%	9144
2021 Q3	$1.32M	Sell	2,491 -1,202	-33%	-$749K	﹤0.01%	6824
2021 Q2	$2.79M	Buy	3,693 +1,033	+39%	+$753K	﹤0.01%	5189
2021 Q1	$2.05M	Buy	2,660 +1,320	+99%	+$1.15M	﹤0.01%	5856
2020 Q4	$703K	Buy	1,340 +466	+53%	+$380K	﹤0.01%	7530
2020 Q3	$887K	Buy	+874	New	+$1.27M	﹤0.01%	6408

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Susquehanna International Group's IBIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in iBio (IBIO) in Q1 2026: 412,725 shares worth $784K. The stake represents ﹤0.01% of the portfolio and ranks #8523 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in IBIO as recently as Q3 2025.

Susquehanna International Group first reported a position in IBIO in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.3M in Q1 2021. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

Susquehanna International Group held 412,725 shares of iBio worth $784K as of Q1 2026.
iBio was a new Susquehanna International Group position in Q1 2026.
iBio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8523 holding.
Susquehanna International Group first reported a position in iBio in Q4 2014 and has held it in 20 quarters since.
Susquehanna International Group's iBio position peaked at $2.3M in Q1 2021.
52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.